Cytosorbents (CTSO) Gains from Investment Securities (2014 - 2017)
Cytosorbents' (CTSO) quarterly Gains from Investment Securities came in at -$618248.0 in Q2 2017, down 424.52% YoY from $190513.0 in Q2 2016, and down 320.98% on a QoQ basis from -$146858.0 in Q1 2017.
Cytosorbents (CTSO) Gains from Investment Securities (2014 - 2017) Analysis & Trends
Cytosorbents (CTSO) has 4 years of Gains from Investment Securities data on file, last reported at -$618248.0 in Q2 2017.
- Quarterly Gains from Investment Securities fell 424.52% year-over-year to -$618248.0 in Q2 2017, while the trailing twelve-month figure through Jun 2017 was -$761907.0 (down 283.22% YoY) and the FY2016 annual result came in at $175418.0, up 113.04% from the prior year.
- Gains from Investment Securities slipped to -$618248.0 in Q2 2017, from -$146858.0 in the prior quarter.
- In the past five years, Gains from Investment Securities ranged from a high of $2.3 million in Q4 2014 to a low of -$3.6 million in Q2 2015.
- A 4-year average of $13108.6 and a median of -$82576.0 in 2016 frame the typical range for Gains from Investment Securities.
- The widest YoY moves for Gains from Investment Securities: up 735.02% in 2015, down 1149.5% in 2015.
- Tracing CTSO's Gains from Investment Securities over 4 years: stood at $2.3 million in 2014, then plunged by 122.68% to -$527712.0 in 2015, then gained by 6.88% to -$491397.0 in 2016, then retreated by 25.81% to -$618248.0 in 2017.
- The last three Gains from Investment Securities figures came in at -$618248.0 (Q2 2017), -$146858.0 (Q1 2017), and -$491397.0 (Q4 2016), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.63 Bn | 194.02 Bn | 7.27 Bn |
| 2 | Stryker | 127.42 Bn | 123.95 Bn | 4.50 Bn |
| 3 | Medtronic | 118.97 Bn | 109.75 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.39 Bn | 72.85 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.97 Bn | 47.72 Bn | 1.35 Bn |
| 6 | Dexcom | 34.32 Bn | 32.37 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.65 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn |
| 9 | Steris | 23.04 Bn | 22.56 Bn | 684.20 Mn |
| 10 | Cytosorbents | 21.41 Mn | 17.00 Mn | 7.05 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2017 | -618,248.00 |
| Jun 30, 2017 | -618,248.00 |
| Mar 31, 2017 | -146,858.00 |
| Mar 31, 2017 | -146,858.00 |
| Dec 31, 2016 | -491,397.00 |
| Dec 31, 2016 | -491,397.00 |
| Sep 30, 2016 | 494,596.00 |
| Sep 30, 2016 | 494,596.00 |
| Jun 30, 2016 | 190,513.00 |
| Jun 30, 2016 | 190,513.00 |
| Mar 31, 2016 | -18,294.00 |
| Mar 31, 2016 | -18,294.00 |
| Dec 31, 2015 | -527,712.00 |
| Dec 31, 2015 | -527,712.00 |
| Sep 30, 2015 | 771,328.00 |
| Sep 30, 2015 | 771,328.00 |
| Jun 30, 2015 | -3.60 Mn |
| Jun 30, 2015 | -3.60 Mn |
| Mar 31, 2015 | 2.01 Mn |
| Mar 31, 2015 | 2.01 Mn |